Tower Research Capital (TRC)’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46K Buy
398
+163
+69% +$2.21K ﹤0.01% 4661
2026
Q1
$6.71K Buy
235
+85
+57% +$2.21K ﹤0.01% 4042
2025
Q4
$4.17K Buy
150
+98
+188% +$5.54K ﹤0.01% 4250
2025
Q3
$3.54K Buy
52
+33
+174% +$2.98K ﹤0.01% 4486
2025
Q2
$2.1K Buy
19
+11
+138% +$3.93K ﹤0.01% 4701
2025
Q1
$3.46K Buy
8
+3
+60% +$1.65K ﹤0.01% 4406
2024
Q4
$3.57K Hold
5
﹤0.01% 4636
2024
Q3
$3.71K Hold
5
﹤0.01% 4789
2024
Q2
$4.25K Hold
5
﹤0.01% 4798
2024
Q1
$5.45K Buy
5
+1
+25% +$1.3K ﹤0.01% 4542
2023
Q4
$6.05K Buy
4
+2
+100% +$2.94K ﹤0.01% 4783
2023
Q3
$6.16K Buy
2
+1
+100% +$3.57K ﹤0.01% 4637
2023
Q2
$4.54K Hold
1
﹤0.01% 4934
2023
Q1
$3K Buy
+1
New +$6.47K ﹤0.01% 5212
2022
Q2
Hold
0
-$8K 6366
2022
Q1
Hold
0
4597
2021
Q4
Hold
0
-$3K 6408
2021
Q3
Hold
0
5119
2021
Q2
Hold
0
5710
2021
Q1
Hold
0
5601
2020
Q3
Hold
0
5004
2020
Q2
Hold
0
4895
2020
Q1
Hold
0
-$1K 3590
2019
Q4
Hold
0
3288
2019
Q3
Hold
0
4372
2019
Q2
Hold
0
4069
2019
Q1
Hold
0
-$1K 4113
2018
Q4
Hold
0
3628
2018
Q3
Hold
0
4083
2018
Q2
Hold
0
-$2K 3913
2018
Q1
Hold
0
2952
2017
Q4
Hold
0
2441

Other funds holding FEED

Tower Research Capital (TRC)'s FEED Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its ENVUE MEDICAL INC NEW (FEED) stake by 69% in Q2 2026, buying an estimated $2.21K and bringing the position to 398 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4661.

Tower Research Capital (TRC) first reported a position in FEED in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.71K in Q1 2026. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

  • Tower Research Capital (TRC) held 398 shares of ENVUE MEDICAL INC NEW worth $2.46K as of Q2 2026.
  • Tower Research Capital (TRC) bought 163 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $2.21K.
  • ENVUE MEDICAL INC NEW made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4661 holding.
  • Tower Research Capital (TRC) first reported a position in ENVUE MEDICAL INC NEW in Q1 2023 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s ENVUE MEDICAL INC NEW position peaked at $6.71K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.